MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nie, Z.
Right arrow Articles by Ramkumar, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nie, Z.
Right arrow Articles by Ramkumar, V.

0026-895X/97/030456-09$3.00/0
Copyright © by The American Society for Pharmacology and Experimental Therapeutics
All rights of reproduction in any form reserved.
MOLECULAR PHARMACOLOGY 52:456-464 (1997).

Short Term Desensitization of the A1 Adenosine Receptors in DDT1MF-2 Cells

Zhongzhen Nie, Yun Mei, and Vickram Ramkumar

Southern Illinois University School of Medicine, Department of Pharmacology, Springfield, Illinois 62794

Previous studies have indicated that desensitization of the A1 adenosine receptor (A1AR), unlike other adenosine receptor subtypes and G protein-coupled receptors, required prolonged exposure to agonists. We more closely studied this observation by focusing on changes in the A1AR signal transduction pathway after short term agonist exposure (0.5-4 hr) in the hamster vas deferens smooth muscle cell line (DDT1MF-2 cells). Incubation of these cells with 1 µM (R)-phenylisopropyladenosine [(R)-PIA] produced a time-dependent loss in binding of the agonist radioligand [125I]N6-2-(4-amino-3-iodophenyl)ethyladenosine but not of the antagonist radioligand [3H]8-cyclopentyl-1,3-dipropylxanthine. This was accompanied by a reduction in the high affinity (G protein-coupled) state of this receptor from 63 ± 8% to 37 ± 12% after treatment for 4 hr. Moreover, cells treated with (R)-PIA demonstrated reduced agonist-stimulated GTPase activity and diminished inhibition of adenylyl cyclase activity but no change in expression of alpha i and beta  subunits. The decreases in agonist binding in the desensitized cells were reversible after treatment of DDT1MF-2 cell membranes with alkaline phosphatase or protein phosphatases 1 and 2A, suggesting a role of phosphorylation in the uncoupling and desensitization of the A1AR. Incubation of cells with (R)-PIA led to rapid translocation of G protein-coupled receptor kinase (GRK) from the cytosol to the plasma membrane within 1 hr of exposure. In addition, purified preparations of the A1AR that were phosphorylated with purified recombinant GRK-2 demonstrated enhanced affinity for arrestin over Gi/Go. These results indicate rapid and functional desensitization of the A1AR by brief exposure to agonist. The mechanism underlying this event seems to involve phosphorylation of the A1AR, presumably by the GRK or GRKs.

Copyright © by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 FASEB J.Home page
S. Tsutsui, D. Vergote, N. Shariat, K. Warren, S. S. G. Ferguson, and C. Power
Glucocorticoids regulate innate immunity in a model of multiple sclerosis: reciprocal interactions between the A1 adenosine receptor and {beta}-arrestin-1 in monocytoid cells
FASEB J, March 1, 2008; 22(3): 786 - 796.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
H. Funakoshi, L. C. Zacharia, Z. Tang, J. Zhang, L. L. Lee, J. C. Good, D. E. Herrmann, Y. Higuchi, W. J. Koch, E. K. Jackson, et al.
A1 Adenosine Receptor Upregulation Accompanies Decreasing Myocardial Adenosine Levels in Mice With Left Ventricular Dysfunction
Circulation, May 1, 2007; 115(17): 2307 - 2315.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
J. P. Wetherington and N. A. Lambert
Differential Desensitization of Responses Mediated by Presynaptic and Postsynaptic A1 Adenosine Receptors
J. Neurosci., February 15, 2002; 22(4): 1248 - 1255.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Bunemann, T. Meyer, L. Pott, and M. Hosey
Novel Inhibition of Gbeta gamma -activated Potassium Currents Induced by M2 Muscarinic Receptors via a Pertussis Toxin-insensitive Pathway
J. Biol. Chem., April 21, 2000; 275(17): 12537 - 12545.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. L. Malek, Z. Nie, V. Ramkumar, and N. H. Lee
Adenosine A2A Receptor mRNA Regulation by Nerve Growth Factor Is TrkA-, Src-, and Ras-dependent via Extracellular Regulated Kinase and Stress-activated Protein Kinase/c-Jun NH2-terminal Kinase
J. Biol. Chem., December 10, 1999; 274(50): 35499 - 35504.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Bouaboula, D. Dussossoy, and P. Casellas
Regulation of Peripheral Cannabinoid Receptor CB2 Phosphorylation by the Inverse Agonist SR 144528. IMPLICATIONS FOR RECEPTOR BIOLOGICAL RESPONSES
J. Biol. Chem., July 16, 1999; 274(29): 20397 - 20405.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
V. Ralevic and G. Burnstock
Receptors for Purines and Pyrimidines
Pharmacol. Rev., September 1, 1998; 50(3): 413 - 492.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics